Web Sify
Follow us on

FDA OKs expanded uses for Xarelto blood thinner

Source : AP
Last Updated: Fri, Nov 02, 2012 22:15 hrs

Johnson & Johnson's Xarelto received an expanded indication as the Food and Drug Administration approved the blood thinner to treat and prevent deep vein thrombosis and pulmonary embolism.

Xarelto already is approved for three uses: for reducing risk of blood clots in people who've had knee replacement surgery or hip replacement surgery and for reducing stroke risk in people with a common irregular heart rhythm, atrial fibrillation, not caused by a heart valve problem.

The New Brunswick, N.J., company markets Xarelto, or rivaroxaban, jointly with Bayer Healthcare.

More from Sify:
blog comments powered by Disqus
  Cities   Price (10g)
  Chennai   Rs. 24500.00 (-0.33%)
  Mumbai   Rs. 25480.00 (-0.08%)
  Delhi   Rs. 25200.00 (0%)
  Kolkata   Rs. 25000.00 (0%)
  Kerala   Rs. 24400.00 (-0.41%)
  Bangalore   Rs. 24450.00 (0%)
  Hyderabad   Rs. 24580.00 (0%)
talking point on sify finance